Wallac Oy, A Subsidiary of Perkinelmer, Inc.

Wallac Oy, A Subsidiary of Perkinelmer, Inc. — FDA 510(k) Submissions

Wallac Oy, A Subsidiary of Perkinelmer, Inc. has submitted 3 FDA 510(k) premarket notifications since 2011, of which 3 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Enzyme Immunoassay, Non-radiolabeled, Total Thyroxine, N-benzoyl-l-arginine Ethyl Ester (u.v.), Trypsin, Enzymatic Methods, Galactose . Use the specialty filter in the sidebar to narrow results.